{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:14:24Z","timestamp":1784142864488,"version":"3.55.0"},"reference-count":124,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T00:00:00Z","timestamp":1701648000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Princess Margaret Cancer Foundation- Lyon Share Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Cancer Surviv"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11764-023-01500-3","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T08:02:32Z","timestamp":1701676952000},"page":"685-700","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Survivorship care for patients curatively treated for Hodgkin\u2019s and non-Hodgkin\u2019s lymphoma: a scoping review"],"prefix":"10.1007","volume":"19","author":[{"given":"Melanie","family":"Powis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saidah","family":"Hack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rouhi","family":"Fazelzad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hodgson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vishal","family":"Kukreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,12,4]]},"reference":[{"key":"1500_CR1","unstructured":"World Cancer Research Fund International. Worldwide cancer data. 2022. https:\/\/www.wcrf.org\/cancer-trends\/worldwide-cancer-data\/. Accessed 10 August 2023."},{"key":"1500_CR2","unstructured":"Cancer Research UK. Hodgkin lymphoma. 2022. https:\/\/tinyurl.com\/yc78czj5 . Accessed 5 September 2023."},{"issue":"9","key":"1500_CR3","doi-asserted-by":"publisher","first-page":"4801","DOI":"10.1002\/cam4.1572","volume":"7","author":"DJ Boyne","year":"2018","unstructured":"Boyne DJ, Mickle AT, Brenner DR, Friedenreich CM, Cheung WY, Tang KL, Wilson TA, Lorenzetti DL, James MT, Ronksley PE, Rabi DM. Long-term risk of cardiovascular mortality in lymphoma survivors: a systematic review and meta-analysis. Cancer Med. 2018;7(9):4801\u201313.","journal-title":"Cancer Med"},{"issue":"6","key":"1500_CR4","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1111\/bjh.14211","volume":"174","author":"AM Williams","year":"2016","unstructured":"Williams AM, Zent CS, Janelsins MC. What is known and unknown about chemotherapy-related cognitive impairment in patients with haematological malignancies and areas of needed research. Br J Haematol. 2016;174(6):835\u201346.","journal-title":"Br J Haematol"},{"issue":"7","key":"1500_CR5","doi-asserted-by":"publisher","first-page":"2453","DOI":"10.1007\/s00520-018-4523-4","volume":"27","author":"JD Troy","year":"2019","unstructured":"Troy JD, Locke SC, Samsa GP, Feliciano J, Richhariya A, LeBlanc TW. Patient-reported distress in Hodgkin lymphoma across the survivorship continuum. Support Care Cancer. 2019;27(7):2453\u201362.","journal-title":"Support Care Cancer"},{"issue":"2","key":"1500_CR6","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1080\/0284186X.2016.1267404","volume":"56","author":"O Husson","year":"2017","unstructured":"Husson O, Prins JB, Kaal SE, Oerlemans S, Stevens WB, Zebrack B, van der Graaf WT, van de Poll-Franse LV. Adolescent and young adult (AYA) lymphoma survivors report lower health-related quality of life compared to a normative population: results from the PROFILES registry. Acta Oncol. 2017;56(2):288\u201394.","journal-title":"Acta Oncol"},{"issue":"17","key":"1500_CR7","doi-asserted-by":"publisher","first-page":"S12","DOI":"10.12968\/bjon.2022.31.17.S12","volume":"31","author":"A Berkley","year":"2022","unstructured":"Berkley A. Support for adult survivors of lymphoma: a literature review. Br J Nurs. 2022;31(17):S12\u20136.","journal-title":"Br J Nurs"},{"issue":"3","key":"1500_CR8","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.12968\/bjon.2020.29.3.S18","volume":"29","author":"L Heveran","year":"2020","unstructured":"Heveran L, Andrewes T. Nursing measures to support the needs of haematological cancer survivors post-treatment: a literature review. Br J Nurs. 2020;29(3):S18\u201324.","journal-title":"Br J Nurs"},{"key":"1500_CR9","volume-title":"From cancer patient to cancer survivor: lost in transition: an American Society of Clinical Oncology and Institute of Medicine symposium","author":"Institute of Medicine and National Research Council","year":"2006","unstructured":"Institute of Medicine and National Research Council. From cancer patient to cancer survivor: lost in transition: an American Society of Clinical Oncology and Institute of Medicine symposium. Washington, DC: The National Academies Press; 2006."},{"key":"1500_CR10","unstructured":"MD Anderson Cancer Centre. Cancer survivorship algorithms. 2023. https:\/\/www.mdanderson.org\/for-physicians\/clinical-tools-resources\/clinical-practice-algorithms\/survivorship-algorithms.html. Accessed 15 September 2022."},{"key":"1500_CR11","unstructured":"National Comprehensive Cancer Network. Survivorship care for cancer-related late or long-term effects. 2020. https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/survivorship-crl-patient.pdf. Accessed 13 September 2022."},{"key":"1500_CR12","unstructured":"American Society of Clinical Oncology. Guidelines on survivorship care. 2023. https:\/\/old-prod.asco.org\/news-initiatives\/current-initiatives\/cancer-care-initiatives\/survivorship-compendium\/guidelines. Accessed 23 September 2022."},{"key":"1500_CR13","unstructured":"American Cancer Society. Key statistics for non-Hodgkin\u2019s lymphoma. 2023. https:\/\/www.cancer.org\/cancer\/non-hodgkin-lymphoma\/about\/key-statistics.html. Accessed 23 September 2022."},{"issue":"3","key":"1500_CR14","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1007\/s11899-017-0382-1","volume":"12","author":"U Zahid","year":"2017","unstructured":"Zahid U, Akbar F, Amaraneni A, Husnain M, Chan O, Riaz IB, McBride A, Iftikhar A, Anwer F. A review of autologous stem cell transplantation in lymphoma. Curr Hematol Malig Rep. 2017;12(3):217\u201326.","journal-title":"Curr Hematol Malig Rep"},{"issue":"7","key":"1500_CR15","doi-asserted-by":"publisher","first-page":"467","DOI":"10.7326\/M18-0850","volume":"169","author":"AC Tricco","year":"2018","unstructured":"Tricco AC, Lillie E, Zarin W, O\u2019Brien KK, Colquhoun H, Levac D, Moher D, Peters MDJ, Horsley T, Weeks L, Hempel S, Akl EA, Chang C, McGowan J, Stewart L, Hartling L, Aldcroft A, Wilson MG, Garritty C, Lewin S, Godfrey CM, Macdonald MT, Langlois EV, Soares-Weiser K, Moriarty J, Clifford T, Tun\u00e7alp \u00d6, Straus SE. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467\u201373.","journal-title":"Ann Intern Med"},{"issue":"5","key":"1500_CR16","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1200\/JCO.2006.09.2403","volume":"25","author":"BD Cheson","year":"2007","unstructured":"Cheson BD, Pfistner B, Juweid ME, Gascoyne RD, Specht L, Horning SJ, Coiffier B, Fisher RI, Hagenbeek A, Zucca E, Rosen ST, Stroobants S, Lister TA, Hoppe RT, Dreyling M, Tobinai K, Vose JM, Connors JM, Federico M, Diehl V, International Harmonization Project on lymphoma. Revised response criteria for malignant lymphoma. J Clin Oncol. 2007;25(5):579\u201386.","journal-title":"J Clin Oncol"},{"issue":"5","key":"1500_CR17","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1002\/pbc.22696","volume":"56","author":"KC Oeffinger","year":"2011","unstructured":"Oeffinger KC, Hudson MM, Mertens AC, Smith SM, Mitby PA, Eshelman-Kent DA, Ford JS, Jones JK, Kamani S, Robison LL. Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan. Pediatr Blood Cancer. 2011;56(5):818\u201324.","journal-title":"Pediatr Blood Cancer"},{"issue":"5","key":"1500_CR18","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1111\/bjh.17206","volume":"193","author":"A Abu Sabaa","year":"2021","unstructured":"Abu Sabaa A, M\u00f6rth C, Hasselblom S, Hedstr\u00f6m G, Flogeg\u00e5rd M, Stern M, Andersson PO, Glimelius I, Enblad G. Age is the most important predictor of survival in diffuse large B-cell lymphoma patients achieving event-free survival at 24 months: a Swedish population-based study. Br J Haematol. 2021;193(5):906\u201314.","journal-title":"Br J Haematol"},{"issue":"4","key":"1500_CR19","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1046\/j.1365-2141.1999.01627.x","volume":"106","author":"DW Milligan","year":"1999","unstructured":"Milligan DW, Ruiz De Elvira MC, Kolb HJ, Goldstone AH, Meloni G, Rohatiner AZ, Colombat P, Schmitz N. Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. EBMT Lymphoma and Late Effects Working Parties. European Group for Blood and Marrow Transplantation. Br J Haematol. 1999;106(4):1020\u20136.","journal-title":"Br J Haematol"},{"issue":"7","key":"1500_CR20","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1200\/JCO.2010.28.9777","volume":"29","author":"C Tarella","year":"2011","unstructured":"Tarella C, Passera R, Magni M, Benedetti F, Rossi A, Gueli A, Patti C, Parvis G, Ciceri F, Gallamini A, Cortelazzo S, Zoli V, Corradini P, Carobbio A, Mul\u00e9 A, Bosa M, Barbui A, Di Nicola M, Sorio M, Caracciolo D, Gianni AM, Rambaldi A. Risk factors for the development of secondary malignancy after high-dose chemotherapy and autograft, with or without rituximab: a 20-year retrospective follow-up study in patients with lymphoma. J Clin Oncol. 2011;29(7):814\u201324.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1500_CR21","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1080\/10428190902756578","volume":"50","author":"T Seshadri","year":"2009","unstructured":"Seshadri T, Pintilie M, Kuruvilla J, Keating A, Tsang R, Zadeh S, Crump M. Incidence and risk factors for second cancers after autologous hematopoietic cell transplantation for aggressive non-Hodgkin lymphoma. Leuk Lymphoma. 2009;50(3):380\u20136.","journal-title":"Leuk Lymphoma"},{"issue":"3","key":"1500_CR22","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1093\/annonc\/mdq408","volume":"22","author":"M Scholz","year":"2011","unstructured":"Scholz M, Engert A, Franklin J, Josting A, Diehl V, Hasenclever D, Loeffler M. Impact of first- and second-line treatment for Hodgkin\u2019s lymphoma on the incidence of AML\/MDS and NHL\u2013experience of the German Hodgkin\u2019s Lymphoma Study Group analyzed by a parametric model of carcinogenesis. Ann Oncol. 2011;22(3):681\u20138.","journal-title":"Ann Oncol"},{"issue":"9","key":"1500_CR23","first-page":"980","volume":"58","author":"E Grunfeld","year":"2012","unstructured":"Grunfeld E, Moineddin R, Gunraj N, Del Giudice ME, Hodgson DC, Kwon JS, Elit L. Cancer screening practices of cancer survivors: population-based, longitudinal study. Can Fam Physician. 2012;58(9):980\u20136.","journal-title":"Can Fam Physician"},{"issue":"8","key":"1500_CR24","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1093\/annonc\/mdq697","volume":"22","author":"M Pirani","year":"2011","unstructured":"Pirani M, Marcheselli R, Marcheselli L, Bari A, Federico M, Sacchi S. Risk for second malignancies in non-Hodgkin\u2019s lymphoma survivors: a meta-analysis. Ann Oncol. 2011;22(8):1845\u201358.","journal-title":"Ann Oncol"},{"issue":"5","key":"1500_CR25","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1111\/bjh.12684","volume":"164","author":"J Lorenzo Bermejo","year":"2014","unstructured":"Lorenzo Bermejo J, Pukkala E, Johannesen TB, Sundquist J, Hemminki K. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden. Br J Haematol. 2014;164(5):675\u201383.","journal-title":"Br J Haematol"},{"issue":"3","key":"1500_CR26","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1093\/annonc\/mdv616","volume":"27","author":"I Fleury","year":"2016","unstructured":"Fleury I, Chevret S, Pfreundschuh M, Salles G, Coiffier B, van Oers MH, Gisselbrecht C, Zucca E, Herold M, Ghielmini M, Thieblemont C. Rituximab and risk of second primary malignancies in patients with non-Hodgkin lymphoma: a systematic review and meta-analysis. Ann Oncol. 2016;27(3):390\u20137.","journal-title":"Ann Oncol"},{"issue":"31","key":"1500_CR27","doi-asserted-by":"publisher","first-page":"4096","DOI":"10.1200\/JCO.2011.34.8268","volume":"29","author":"AJ Swerdlow","year":"2011","unstructured":"Swerdlow AJ, Higgins CD, Smith P, Cunningham D, Hancock BW, Horwich A, Hoskin PJ, Lister TA, Radford JA, Rohatiner AZ, Linch DC. Second cancer risk after chemotherapy for Hodgkin\u2019s lymphoma: a collaborative British cohort study. J Clin Oncol. 2011;29(31):4096\u2013104.","journal-title":"J Clin Oncol"},{"issue":"6","key":"1500_CR28","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1002\/cncr.31903","volume":"125","author":"LS Rigter","year":"2019","unstructured":"Rigter LS, Spaander MCW, Aleman BMP, Bisseling TM, Moons LM, Cats A, Lugtenburg PJ, Janus CPM, Petersen EJ, Roesink JM, van der Maazen RWM, Snaebjornsson P, Kuipers EJ, Bruno MJ, Dekker E, Meijer GA, de Boer JP, van Leeuwen FE, van Leerdam ME. High prevalence of advanced colorectal neoplasia and serrated polyposis syndrome in Hodgkin lymphoma survivors. Cancer. 2019;125(6):990\u20139.","journal-title":"Cancer"},{"issue":"3","key":"1500_CR29","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/bjc.2017.177","volume":"117","author":"AM van Eggermond","year":"2017","unstructured":"van Eggermond AM, Schaapveld M, Janus CP, de Boer JP, Krol AD, Zijlstra JM, van der Maazen RW, Kremer LC, van Leerdam ME, Louwman MW, Visser O, De Bruin ML, Aleman BM, van Leeuwen FE. Infradiaphragmatic irradiation and high procarbazine doses increase colorectal cancer risk in Hodgkin lymphoma survivors. Br J Cancer. 2017;117(3):306\u201314.","journal-title":"Br J Cancer"},{"issue":"11","key":"1500_CR30","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1093\/jnci\/djz060","volume":"111","author":"A Gini","year":"2019","unstructured":"Gini A, Meester RGS, Keshavarz H, Oeffinger KC, Ahmed S, Hodgson DC, Lansdorp-Vogelaar I. Cost-effectiveness of colonoscopy-based colorectal cancer screening in childhood cancer survivors. J Natl Cancer Inst. 2019;111(11):1161\u20139.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1500_CR31","doi-asserted-by":"publisher","first-page":"190","DOI":"10.3390\/jcm9010190","volume":"9","author":"B Ykema","year":"2020","unstructured":"Ykema B, Rigter L, Spaander M, Moons L, Bisseling T, Aleman B, de Boer JP, Lugtenburg P, Janus C, Petersen E, Roesink J, Raemaekers J, van der Maazen R, Lansdorp-Vogelaar I, Gini A, Verbeek W, Lemmens M, Meijer G, van Leeuwen F, Snaebjornsson P, Carvalho B, van Leerdam M. Diagnostic accuracy of stool tests for colorectal cancer surveillance in Hodgkin lymphoma survivors. J Clin Med. 2020;9(1):190.","journal-title":"J Clin Med"},{"key":"1500_CR32","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1186\/1471-2407-12-197","volume":"12","author":"EM Ibrahim","year":"2012","unstructured":"Ibrahim EM, Abouelkhair KM, Kazkaz GA, Elmasri OA, Al-Foheidi M. Risk of second breast cancer in female Hodgkin\u2019s lymphoma survivors: a meta-analysis. BMC Cancer. 2012;12:197.","journal-title":"BMC Cancer"},{"issue":"18","key":"1500_CR33","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1200\/JCO.2010.32.4079","volume":"29","author":"EB Elkin","year":"2011","unstructured":"Elkin EB, Klem ML, Gonzales AM, Ishill NM, Hodgson D, Ng AK, Marks LB, Weidhaas J, Freedman GM, Miller RC, Constine LS, Myrehaug S, Yahalom J. Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin\u2019s lymphoma: a multi-institutional, matched cohort study. J Clin Oncol. 2011;29(18):2466\u201373.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1500_CR34","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1093\/annonc\/mdl399","volume":"18","author":"G Sanna","year":"2007","unstructured":"Sanna G, Lorizzo K, Rotmensz N, Bagnardi V, Cinieri S, Colleoni M, Nol\u00e8 F, Goldhirsch A. Breast cancer in Hodgkin\u2019s disease and non-Hodgkin\u2019s lymphoma survivors. Ann Oncol. 2007;18(2):288\u201392.","journal-title":"Ann Oncol"},{"issue":"1","key":"1500_CR35","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/jnci\/djz037","volume":"112","author":"J Furzer","year":"2020","unstructured":"Furzer J, Tessier L, Hodgson D, Cotton C, Nathan PC, Gupta S, Pechlivanoglou P. Cost-utility of early breast cancer surveillance in survivors of thoracic radiation-treated adolescent Hodgkin lymphoma. J Natl Cancer Inst. 2020;112(1):63\u201370.","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"1500_CR36","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1200\/JCO.2012.46.5732","volume":"31","author":"AK Ng","year":"2013","unstructured":"Ng AK, Garber JE, Diller LR, Birdwell RL, Feng Y, Neuberg DS, Silver B, Fisher DC, Marcus KJ, Mauch PM. Prospective study of the efficacy of breast magnetic resonance imaging and mammographic screening in survivors of Hodgkin lymphoma. J Clin Oncol. 2013;31(18):2282\u20138.","journal-title":"J Clin Oncol"},{"key":"1500_CR37","doi-asserted-by":"publisher","unstructured":"Hodgson DC, Cotton C, Crystal P, Nathan PC. Impact of early breast cancer screening on mortality among young survivors of childhood Hodgkin\u2019s lymphoma. J Natl Cancer Inst. 2016;108(7). https:\/\/doi.org\/10.1093\/jnci\/djw010.","DOI":"10.1093\/jnci\/djw010"},{"issue":"1","key":"1500_CR38","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s00408-012-9418-4","volume":"191","author":"EM Ibrahim","year":"2013","unstructured":"Ibrahim EM, Kazkaz GA, Abouelkhair KM, Al-Mansour MM, Al-Fayea TM, Al-Foheidi M, Bayer AM, Elmasri OA. Increased risk of second lung cancer in Hodgkin\u2019s lymphoma survivors: a meta-analysis. Lung. 2013;191(1):117\u201334.","journal-title":"Lung"},{"issue":"2","key":"1500_CR39","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.ijrobp.2014.06.013","volume":"90","author":"DA Wattson","year":"2014","unstructured":"Wattson DA, Hunink MG, DiPiro PJ, Das P, Hodgson DC, Mauch PM, Ng AK. Low-dose chest computed tomography for lung cancer screening among Hodgkin lymphoma survivors: a cost-effectiveness analysis. Int J Radiat Oncol Biol Phys. 2014;90(2):344\u201353.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"1","key":"1500_CR40","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1111\/hex.13353","volume":"25","author":"R Broadbent","year":"2022","unstructured":"Broadbent R, Gorman L, Armitage CJ, Radford J, Linton K. The perspectives of survivors of Hodgkin lymphoma on lung cancer screening: a qualitative study. Health Expect. 2022;25(1):116\u201324.","journal-title":"Health Expect"},{"issue":"2","key":"1500_CR41","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/ijc.20713","volume":"114","author":"C Nord","year":"2005","unstructured":"Nord C, Mykletun A, Thorsen L, Bj\u00f8ro T, Foss\u00e5 SD. Self-reported health and use of health care services in long-term cancer survivors. Int J Cancer. 2005;114(2):307\u201316.","journal-title":"Int J Cancer"},{"issue":"2","key":"1500_CR42","doi-asserted-by":"publisher","first-page":"122","DOI":"10.3816\/CLM.2005.n.038","volume":"6","author":"EC Moser","year":"2005","unstructured":"Moser EC, Noordijk EM, Carde P, Tirelli U, Baars JW, Thomas J, Bron D, Meerwaldt JH, van Glabbeke M, Raemaekers JM, Kluin-Nelemans HC. Late non-neoplastic events in patients with aggressive non-Hodgkin\u2019s lymphoma in four randomized European Organisation for Research and Treatment of Cancer trials. Clin Lymphoma Myeloma. 2005;6(2):122\u201330.","journal-title":"Clin Lymphoma Myeloma"},{"issue":"4","key":"1500_CR43","doi-asserted-by":"publisher","first-page":"e13067","DOI":"10.1111\/ecc.13067","volume":"28","author":"A Immanuel","year":"2019","unstructured":"Immanuel A, Hunt J, McCarthy H, van Teijlingen E, Sheppard ZA. Quality of life in survivors of adult haematological malignancy. Eur J Cancer Care (Engl). 2019;28(4):e13067.","journal-title":"Eur J Cancer Care (Engl)"},{"issue":"25","key":"1500_CR44","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.1200\/JCO.19.03160","volume":"38","author":"S Kreissl","year":"2020","unstructured":"Kreissl S, M\u00fcller H, Goergen H, Meissner J, Topp M, S\u00f6kler M, Markova J, Bernhard J, Greil R, von Tresckow B, Behringer K, R\u00fcffer JU, Flechtner HH, M\u00f6stl M, Fuchs M, Engert A, Diehl V, Borchmann P. Health-related quality of life in patients with Hodgkin lymphoma: a longitudinal analysis of the German Hodgkin Study Group. J Clin Oncol. 2020;38(25):2839\u201348.","journal-title":"J Clin Oncol"},{"issue":"10","key":"1500_CR45","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1016\/j.bbmt.2007.06.003","volume":"13","author":"NS Majhail","year":"2007","unstructured":"Majhail NS, Ness KK, Burns LJ, Sun CL, Carter A, Francisco L, Forman SJ, Bhatia S, Baker KS. Late effects in survivors of Hodgkin and non-Hodgkin lymphoma treated with autologous hematopoietic cell transplantation: a report from the bone marrow transplant survivor study. Biol Blood Marrow Transplant. 2007;13(10):1153\u20139.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"1500_CR46","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/j.diabres.2011.08.029","volume":"95","author":"HS Jung","year":"2012","unstructured":"Jung HS, Myung SK, Kim BS, Seo HG. Metabolic syndrome in adult cancer survivors: a meta-analysis. Diabetes Res Clin Pract. 2012;95(2):275\u201382.","journal-title":"Diabetes Res Clin Pract"},{"issue":"5","key":"1500_CR47","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1111\/bjh.15448","volume":"182","author":"E Trachtenberg","year":"2018","unstructured":"Trachtenberg E, Mashiach T, Ben Hayun R, Tadmor T, Fisher T, Aharon-Peretz J, Dann EJ. Cognitive impairment in Hodgkin lymphoma survivors. Br J Haematol. 2018;182(5):670\u20138.","journal-title":"Br J Haematol"},{"issue":"12","key":"1500_CR48","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1016\/S1470-2045(09)70258-X","volume":"10","author":"N Heutte","year":"2009","unstructured":"Heutte N, Flechtner HH, Mounier N, Mellink WA, Meerwaldt JH, Eghbali H, van\u2019t Veer MB, Noordijk EM, Kluin-Nelemans JC, Lampka E, Thomas J, Lugtenburg PJ, Viterbo L, Carde P, Hagenbeek A, van der Maazen RW, Smit WG, Brice P, van MarwijkKooy M, Baars JW, Poortmans P, Tirelli U, Leeksma OC, Tomsic R, Feugier P, Salles G, Gabarre J, Kersten MJ, Van Den Neste E, Creemers GJ, Gaillard I, Meijnders P, Tertian G, Reman O, Muller HP, Troncy J, Blanc M, Schroyens W, Voogt PJ, Wijermans P, Rieux C, Ferm\u00e9 C, Henry-Amar M, EORTC-GELA H8 Trial Group. Quality of life after successful treatment of early-stage Hodgkin\u2019s lymphoma: 10-year follow-up of the EORTC-GELA H8 randomised controlled trial. Lancet Oncol. 2009;10(12):1160\u201370.","journal-title":"Lancet Oncol"},{"issue":"15","key":"1500_CR49","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.1016\/S0959-8049(03)00545-8","volume":"39","author":"JU R\u00fcffer","year":"2003","unstructured":"R\u00fcffer JU, Flechtner H, Tralls P, Josting A, Sieber M, Lathan B, Diehl V, German Hodgkin Lymphoma Study Group. Fatigue in long-term survivors of Hodgkin\u2019s lymphoma; a report from the German Hodgkin Lymphoma Study Group (GHSG). Eur J Cancer. 2003;39(15):2179\u201386.","journal-title":"Eur J Cancer"},{"issue":"10","key":"1500_CR50","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1016\/S1470-2045(16)30093-6","volume":"17","author":"S Kreissl","year":"2016","unstructured":"Kreissl S, Mueller H, Goergen H, Mayer A, Brillant C, Behringer K, Halbsguth TV, Hitz F, Soekler M, Shonukan O, Rueffer JU, Flechtner HH, Fuchs M, Diehl V, Engert A, Borchmann P, German Hodgkin Study Group. Cancer-related fatigue in patients with and survivors of Hodgkin\u2019s lymphoma: a longitudinal study of the German Hodgkin Study Group. Lancet Oncol. 2016;17(10):1453\u201362.","journal-title":"Lancet Oncol"},{"issue":"1","key":"1500_CR51","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12955-019-1186-x","volume":"17","author":"R Busson","year":"2019","unstructured":"Busson R, van der Kaaij M, Mounier N, Aleman BMP, Thi\u00e9blemont C, Stamatoullas A, Ribrag V, Tilly H, Haioun C, Casasnovas RO, Kluin-Nelemans HC, Henry-Amar M. Fatigue level changes with time in long-term Hodgkin and non-Hodgkin lymphoma survivors: a joint EORTC-LYSA cross-sectional study. Health Qual Life Outcomes. 2019;17(1):115.","journal-title":"Health Qual Life Outcomes"},{"issue":"1","key":"1500_CR52","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1177\/0748730420987327","volume":"36","author":"DEJ Starreveld","year":"2021","unstructured":"Starreveld DEJ, Habers GEA, Valdimarsdottir HB, Kessels R, Dani\u00ebls LA, van Leeuwen FE, Bleiker EMA. Cancer-related fatigue in relation to chronotype and sleep quality in (non-)Hodgkin lymphoma survivors. J Biol Rhythms. 2021;36(1):71\u201383.","journal-title":"J Biol Rhythms"},{"issue":"10","key":"1500_CR53","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1037\/hea0000921","volume":"39","author":"N Stadtbaeumer","year":"2020","unstructured":"Stadtbaeumer N, M\u00fcller H, Goergen H, Kreissl S, Borchmann P, Mayer A. The interplay between cancer-related fatigue and functional health in Hodgkin lymphoma survivors. Health Psychol. 2020;39(10):905\u201311.","journal-title":"Health Psychol"},{"issue":"3","key":"1500_CR54","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s11764-020-00941-4","volume":"15","author":"S Hathiramani","year":"2021","unstructured":"Hathiramani S, Pettengell R, Moir H, Younis A. Relaxation versus exercise for improved quality of life in lymphoma survivors-a randomised controlled trial. J Cancer Surviv. 2021;15(3):470\u201380.","journal-title":"J Cancer Surviv"},{"issue":"11","key":"1500_CR55","doi-asserted-by":"publisher","first-page":"4069","DOI":"10.1007\/s00520-019-04983-y","volume":"27","author":"L Liu","year":"2019","unstructured":"Liu L, He X, Feng L. Exercise on quality of life and cancer-related fatigue for lymphoma survivors: a systematic review and meta-analysis. Support Care Cancer. 2019;27(11):4069\u201382.","journal-title":"Support Care Cancer"},{"issue":"16","key":"1500_CR56","doi-asserted-by":"publisher","first-page":"4076","DOI":"10.3390\/cancers13164076","volume":"13","author":"L Fauske","year":"2021","unstructured":"Fauske L, Bruland \u00d8S, Dahl AA, Myklebostad A, Reme SE. Does the lightning process training programme reduce chronic fatigue in adolescent and young adult cancer survivors? A mixed-methods pilot study. Cancers (Basel). 2021;13(16):4076.","journal-title":"Cancers (Basel)"},{"issue":"19","key":"1500_CR57","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.3390\/cancers13194948","volume":"13","author":"DEJ Starreveld","year":"2021","unstructured":"Starreveld DEJ, Daniels LA, Kieffer JM, Valdimarsdottir HB, de Geus J, Lanfermeijer M, van Someren EJW, Habers GEA, Bosch JA, Janus CPM, van Spronsen DJ, de Weijer RJ, Marijt EWA, de Jongh E, Zijlstra JM, B\u00f6hmer LH, Houmes M, Kersten MJ, Korse CM, van Rossum HH, Redd WH, Lutgendorf SK, Ancoli-Israel S, van Leeuwen FE, Bleiker EMA. Light therapy for cancer-related fatigue in (non-)Hodgkin lymphoma survivors: results of a randomized controlled trial. Cancers (Basel). 2021;13(19):4948.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"1500_CR58","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1016\/j.jgo.2020.01.007","volume":"11","author":"D La Carpia","year":"2020","unstructured":"La Carpia D, Liperoti R, Guglielmo M, Di Capua B, Devizzi LF, Matteucci P, Farina L, Fusco D, Colloca G, Di Pede P, Ferrara ML, Hohaus S, Bernabei R, Ripamonti CI. Cognitive decline in older long-term survivors from non-Hodgkin lymphoma: a multicenter cross-sectional study. J Geriatr Oncol. 2020;11(5):790\u20135.","journal-title":"J Geriatr Oncol"},{"issue":"4","key":"1500_CR59","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1080\/0284186X.2016.1267870","volume":"56","author":"M Seland","year":"2017","unstructured":"Seland M, Smeland KB, Bj\u00f8ro T, Falk RS, Foss\u00e5 SD, Gjesdal CG, Godang K, Holte H, Svartberg J, Syversen U, Bollerslev J, Kiserud CE. Bone mineral density is close to normal for age in long-term lymphoma survivors treated with high-dose therapy with autologous stem cell transplantation. Acta Oncol. 2017;56(4):590\u20138.","journal-title":"Acta Oncol"},{"issue":"8","key":"1500_CR60","doi-asserted-by":"publisher","first-page":"1486","DOI":"10.1080\/10428190802140873","volume":"49","author":"S Myrehaug","year":"2008","unstructured":"Myrehaug S, Pintilie M, Tsang R, Mackenzie R, Crump M, Chen Z, Sun A, Hodgson DC. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leuk Lymphoma. 2008;49(8):1486\u201393.","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"1500_CR61","doi-asserted-by":"publisher","first-page":"e492","DOI":"10.1016\/S2352-3026(15)00153-2","volume":"2","author":"MV Maraldo","year":"2015","unstructured":"Maraldo MV, Giusti F, Vogelius IR, Lundemann M, van der Kaaij MA, Ramadan S, Meulemans B, Henry-Amar M, Aleman BM, Raemaekers J, Meijnders P, Moser EC, Kluin-Nelemans HC, Feugier P, Casasnovas O, Fortpied C, Specht L, European Organisation for Research and Treatment of Cancer (EORTC) Lymphoma Group. Cardiovascular disease after treatment for Hodgkin\u2019s lymphoma: an analysis of nine collaborative EORTC-LYSA trials. Lancet Haematol. 2015;2(11):e492-502.","journal-title":"Lancet Haematol"},{"issue":"7","key":"1500_CR62","doi-asserted-by":"publisher","first-page":"908","DOI":"10.1016\/j.cjca.2015.12.020","volume":"32","author":"MT Nolan","year":"2016","unstructured":"Nolan MT, Russell DJ, Marwick TH. Long-term risk of heart failure and myocardial dysfunction after thoracic radiotherapy: a systematic review. Can J Cardiol. 2016;32(7):908\u201320.","journal-title":"Can J Cardiol"},{"issue":"6","key":"1500_CR63","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.echo.2016.02.014","volume":"29","author":"K Murbraech","year":"2016","unstructured":"Murbraech K, Holte E, Broch K, Smeland KB, Holte H, R\u00f6sner A, Lund MB, Dalen H, Kiserud C, Aakhus S. Impaired right ventricular function in long-term lymphoma survivors. J Am Soc Echocardiogr. 2016;29(6):528\u201336.","journal-title":"J Am Soc Echocardiogr"},{"issue":"10","key":"1500_CR64","doi-asserted-by":"publisher","first-page":"e135","DOI":"10.1002\/hsr2.135","volume":"2","author":"CR Stone","year":"2019","unstructured":"Stone CR, Mickle AT, Boyne DJ, Mohamed A, Rabi DM, Brenner DR, Friedenreich CM. Treatment for lymphoma and late cardiovascular disease risk: a systematic review and meta-analysis. Health Sci Rep. 2019;2(10):e135.","journal-title":"Health Sci Rep"},{"issue":"13","key":"1500_CR65","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1093\/jnci\/djp147","volume":"101","author":"ML De Bruin","year":"2009","unstructured":"De Bruin ML, Dorresteijn LD, van\u2019t Veer MB, Krol AD, van der Pal HJ, Kappelle AC, Boogerd W, Aleman BM, van Leeuwen FE. Increased risk of stroke and transient ischemic attack in 5-year survivors of Hodgkin lymphoma. J Natl Cancer Inst. 2009;101(13):928\u201337.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1500_CR66","doi-asserted-by":"publisher","first-page":"dju110","DOI":"10.1093\/jnci\/dju110","volume":"106","author":"K Rugbjerg","year":"2014","unstructured":"Rugbjerg K, Mellemkjaer L, Boice JD, K\u00f8ber L, Ewertz M, Olsen JH. Cardiovascular disease in survivors of adolescent and young adult cancer: a Danish cohort study, 1943\u20132009. J Natl Cancer Inst. 2014;106(6):dju110.","journal-title":"J Natl Cancer Inst"},{"issue":"6","key":"1500_CR67","doi-asserted-by":"publisher","first-page":"5212","DOI":"10.1016\/j.ijcard.2013.08.033","volume":"168","author":"W Jurczak","year":"2013","unstructured":"Jurczak W, Szmit S, Soboci\u0144ski M, Machaczka M, Drozd-Soko\u0142owska J, Joks M, Dzietczenia J, Wr\u00f3bel T, Kumiega B, Zaucha JM, Knopi\u0144ska-Pos\u0142uszny W, Spycha\u0142owicz W, Prochwicz A, Drohomirecka A, Skotnicki AB. Premature cardiovascular mortality in lymphoma patients treated with (R)-CHOP regimen - a national multicenter study. Int J Cardiol. 2013;168(6):5212\u20137.","journal-title":"Int J Cardiol"},{"issue":"7","key":"1500_CR68","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1080\/10428190500063229","volume":"46","author":"A Avil\u00e9s","year":"2005","unstructured":"Avil\u00e9s A, Neri N, Nambo JM, Huerta-Guzman J, Talavera A, Cleto S. Late cardiac toxicity secondary to treatment in Hodgkin\u2019s disease. A study comparing doxorubicin, epirubicin and mitoxantrone in combined therapy. Leuk Lymphoma. 2005;46(7):1023\u20138.","journal-title":"Leuk Lymphoma"},{"issue":"7","key":"1500_CR69","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1093\/annonc\/mdr575","volume":"23","author":"K Behringer","year":"2012","unstructured":"Behringer K, Thielen I, Mueller H, Goergen H, Eibl AD, Rosenbrock J, Halbsguth T, Eichenauer DA, Fuchs M, Reiners KS, Renno JH, van der Ven K, Kuehr M, von Wolff M, Diehl V, Engert A, Borchmann P. Fertility and gonadal function in female survivors after treatment of early unfavorable Hodgkin lymphoma (HL) within the German Hodgkin Study Group HD14 trial. Ann Oncol. 2012;23(7):1818\u201325.","journal-title":"Ann Oncol"},{"issue":"2","key":"1500_CR70","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1200\/JCO.2012.44.3721","volume":"31","author":"K Behringer","year":"2013","unstructured":"Behringer K, Mueller H, Goergen H, Thielen I, Eibl AD, Stumpf V, Wessels C, Wiehlp\u00fctz M, Rosenbrock J, Halbsguth T, Reiners KS, Schober T, Renno JH, von Wolff M, van der Ven K, Kuehr M, Fuchs M, Diehl V, Engert A, Borchmann P. Gonadal function and fertility in survivors after Hodgkin lymphoma treatment within the German Hodgkin Study Group HD13 to HD15 trials. J Clin Oncol. 2013;31(2):231\u20139.","journal-title":"J Clin Oncol"},{"issue":"3","key":"1500_CR71","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1093\/humrep\/det430","volume":"29","author":"MA van der Kaaij","year":"2014","unstructured":"van der Kaaij MA, van Echten-Arends J, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Lugtenburg PJ, Aleman BM, Noordijk EM, Ferm\u00e9 C, Thomas J, Stamatoullas A, Fruchart C, Eghbali H, Brice P, Smit WG, Sebban C, Doorduijn JK, Roesink JM, Gaillard I, Coiffier B, Lybeert ML, Casasnovas O, Andr\u00e9 M, Raemaekers JM, Henry-Amar M, Kluin-Nelemans JC, European Organisation for Research and Treatment of Cancer Lymphoma Group and the Grouped\u2019\u00c9tude des Lymphomes de l\u2019Adulte. Cryopreservation, semen use and the likelihood of fatherhood in male Hodgkin lymphoma survivors: an EORTC-GELA Lymphoma Group cohort study. Hum Reprod. 2014;29(3):525\u201333.","journal-title":"Hum Reprod"},{"issue":"3","key":"1500_CR72","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1200\/JCO.2011.37.1989","volume":"30","author":"MA van der Kaaij","year":"2012","unstructured":"van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser EC, Allgeier A, Meulemans B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Ferm\u00e9 C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Bologna S, Ong F, Eghbali H, Doorduijn JK, Morschhauser F, Sebban C, Roesink JM, Bouteloup M, Van Hoof A, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. Premature ovarian failure and fertility in long-term survivors of Hodgkin\u2019s lymphoma: a European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d\u2019Etude des Lymphomes de l\u2019Adulte Cohort Study. J Clin Oncol. 2012;30(3):291\u20139.","journal-title":"J Clin Oncol"},{"issue":"31","key":"1500_CR73","doi-asserted-by":"publisher","first-page":"3854","DOI":"10.1200\/JCO.2011.40.8906","volume":"30","author":"MA van der Kaaij","year":"2012","unstructured":"van der Kaaij MA, Heutte N, Meijnders P, Abeilard-Lemoisson E, Spina M, Moser LC, Allgeier A, Meulemans B, Dubois B, Simons AH, Lugtenburg PJ, Aleman BM, Noordijk EM, Ferm\u00e9 C, Thomas J, Stamatoullas A, Fruchart C, Brice P, Gaillard I, Doorduijn JK, Sebban C, Smit WG, Bologna S, Roesink JM, Ong F, Andr\u00e9 MP, Raemaekers JM, Henry-Amar M, Kluin-Nelemans HC. Parenthood in survivors of Hodgkin lymphoma: an EORTC-GELA general population case-control study. J Clin Oncol. 2012;30(31):3854\u201363.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1500_CR74","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1002\/hon.2029","volume":"31","author":"S Falorio","year":"2013","unstructured":"Falorio S, Biasoli I, Luminari S, Quintana G, Musso M, Dell\u2019olio M, Specchia MR, di Renzo N, Cesaretti M, Buda G, Vallisa D, Mannina D, Andriani A, Chiattone CS, Delamain MT, de Souza CA, Spector N, Angrilli F, Federico M. Risk factors for impaired gonadal function in female Hodgkin lymphoma survivors: final analysis of a retrospective multicenter joint study from Italian and Brazilian Institutions. Hematol Oncol. 2013;31(2):72\u20138.","journal-title":"Hematol Oncol"},{"issue":"22","key":"1500_CR75","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","volume":"34","author":"I Demeestere","year":"2016","unstructured":"Demeestere I, Brice P, Peccatori FA, Kentos A, Dupuis J, Zachee P, Casasnovas O, Van Den Neste E, Dechene J, De Maertelaer V, Bron D, Englert Y. No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final long-term report of a prospective randomized trial. J Clin Oncol. 2016;34(22):2568\u201374.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1500_CR76","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1080\/10245330600954072","volume":"12","author":"L Giuseppe","year":"2007","unstructured":"Giuseppe L, Attilio G, Edoardo DN, Loredana G, Cristina L, Vincenzo L. Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD). Hematology. 2007;12(2):141\u20137.","journal-title":"Hematology"},{"issue":"1","key":"1500_CR77","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.rbmo.2020.02.008","volume":"41","author":"A Busnelli","year":"2020","unstructured":"Busnelli A, Vitagliano A, Mensi L, Acerboni S, Bulfoni A, Filippi F, Somigliana E. Fertility in female cancer survivors: a systematic review and meta-analysis. Reprod Biomed Online. 2020;41(1):96\u2013112.","journal-title":"Reprod Biomed Online"},{"issue":"8","key":"1500_CR78","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.1001\/jamaoncol.2017.0029","volume":"3","author":"C Anderson","year":"2017","unstructured":"Anderson C, Engel SM, Mersereau JE, Black KZ, Wood WA, Anders CK, Nichols HB. Birth outcomes among adolescent and young adult cancer survivors. JAMA Oncol. 2017;3(8):1078\u201384.","journal-title":"JAMA Oncol"},{"key":"1500_CR79","doi-asserted-by":"publisher","first-page":"204062072095500","DOI":"10.1177\/2040620720955002","volume":"11","author":"P Goswami","year":"2020","unstructured":"Goswami P, Oliva EN, Ionova T, Else R, Kell J, Fielding AK, Jennings DM, Karakantza M, Al-Ismail S, Collins GP, McConnell S, Langton C, Salek S. Quality-of-life issues and symptoms reported by patients living with haematological malignancy: a qualitative study. Ther Adv Hematol. 2020;11:2040620720955002.","journal-title":"Ther Adv Hematol"},{"issue":"3","key":"1500_CR80","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1037\/hea0000713","volume":"38","author":"K Kuba","year":"2019","unstructured":"Kuba K, Esser P, Mehnert A, Hinz A, Johansen C, Lordick F, G\u00f6tze H. Risk for depression and anxiety in long-term survivors of hematologic cancer. Health Psychol. 2019;38(3):187\u201395.","journal-title":"Health Psychol"},{"issue":"2","key":"1500_CR81","first-page":"e21","volume":"2","author":"C Cunningham","year":"2020","unstructured":"Cunningham C, Wakim P, Hendricks J, Cassidy Q, Telgen E, BrintzenhofeSzoc K. Influence of psychosocial distress on traumatic stress symptoms among oncology patients in clinical trials. J Psychosocial Oncol Res Pract. 2020;2(2):e21.","journal-title":"J Psychosocial Oncol Res Pract"},{"issue":"4","key":"1500_CR82","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1111\/jrh.12420","volume":"36","author":"D Noonan","year":"2020","unstructured":"Noonan D, LeBlanc M, Conley C, Benecha H, Leak-Bryant A, Peter K, Zimmerman S, Mayer D, Smith S. Quality of life and impact of cancer: differences in rural and nonrural non-Hodgkin\u2019s lymphoma survivors. J Rural Health. 2020;36(4):536\u201342.","journal-title":"J Rural Health"},{"issue":"11","key":"1500_CR83","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1002\/pon.910","volume":"14","author":"JK Vallance","year":"2005","unstructured":"Vallance JK, Courneya KS, Jones LW, Reiman T. Differences in quality of life between non-Hodgkin\u2019s lymphoma survivors meeting and not meeting public health exercise guidelines. Psychooncology. 2005;14(11):979\u201391.","journal-title":"Psychooncology"},{"issue":"11","key":"1500_CR84","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.1007\/s00520-021-06246-1","volume":"29","author":"P Lekdamrongkul","year":"2021","unstructured":"Lekdamrongkul P, Pongthavornkamol K, Molassiotis A, Sriyuktasuth A, Siritanaratkul N, Chansatitporn N. Exploring health-related quality of life among non-Hodgkin\u2019s lymphoma survivors after completion of primary treatment: a cross-sectional study in Thailand. Support Care Cancer. 2021;29(11):6511\u201322.","journal-title":"Support Care Cancer"},{"issue":"7","key":"1500_CR85","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1037\/hea0000754","volume":"38","author":"C S\u00e9guin Leclair","year":"2019","unstructured":"S\u00e9guin Leclair C, Lebel S, Westmaas JL. The relationship between fear of cancer recurrence and health behaviors: a nationwide longitudinal study of cancer survivors. Health Psychol. 2019;38(7):596\u2013605.","journal-title":"Health Psychol"},{"issue":"3","key":"1500_CR86","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1080\/07347332.2019.1677840","volume":"38","author":"LE Latella","year":"2020","unstructured":"Latella LE, Rogers M, Leventhal H, Parker PA, Horwitz S, Matasar MJ, Bylund CL, Kissane DW, Franco K, Banerjee SC. Fear of cancer recurrence in lymphoma survivors: a descriptive study. J Psychosoc Oncol. 2020;38(3):251\u201371.","journal-title":"J Psychosoc Oncol"},{"issue":"6","key":"1500_CR87","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/pon.5371","volume":"29","author":"PA Parker","year":"2020","unstructured":"Parker PA, Banerjee SC, Matasar MJ, Bylund CL, Schofield E, Li Y, Jacobsen PB, Astrow AB, Leventhal H, Horwitz S, Kissane D. Cancer worry and empathy moderate the effect of a survivorship-focused intervention on quality of life. Psychooncology. 2020;29(6):1012\u20138.","journal-title":"Psychooncology"},{"issue":"7","key":"1500_CR88","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1037\/hea0000869","volume":"39","author":"K Vargas-Rom\u00e1n","year":"2020","unstructured":"Vargas-Rom\u00e1n K, D\u00edaz-Rodr\u00edguez CL, Ca\u00f1adas-De la Fuente GA, G\u00f3mez-Urquiza JL, Ariza T, De la Fuente-Solana EI. Anxiety prevalence in lymphoma a systematic review and meta-analysis. Health Psychol. 2020;39(7):580\u20138.","journal-title":"Health Psychol"},{"issue":"2","key":"1500_CR89","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s11764-020-00858-y","volume":"14","author":"Y Rottenberg","year":"2020","unstructured":"Rottenberg Y, de Boer AGEM. Risk for unemployment at 10 years following cancer diagnosis among very long-term survivors: a population based study. J Cancer Surviv. 2020;14(2):151\u20137.","journal-title":"J Cancer Surviv"},{"issue":"3","key":"1500_CR90","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1089\/jayao.2018.0109","volume":"8","author":"AA Dahl","year":"2019","unstructured":"Dahl AA, Foss\u00e5 SD, Lie HC, Loge JH, Reinertsen KV, Ruud E, Kiserud CE. Employment status and work ability in long-term young adult cancer survivors. J Adolesc Young Adult Oncol. 2019;8(3):304\u201311.","journal-title":"J Adolesc Young Adult Oncol"},{"issue":"11","key":"1500_CR91","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1002\/cncr.31985","volume":"125","author":"TG Ketterl","year":"2019","unstructured":"Ketterl TG, Syrjala KL, Casillas J, Jacobs LA, Palmer SC, McCabe MS, Ganz PA, Overholser L, Partridge A, Rajotte EJ, Rosenberg AR, Risendal B, Rosenstein DL, Baker KS. Lasting effects of cancer and its treatment on employment and finances in adolescent and young adult cancer survivors. Cancer. 2019;125(11):1908\u201317.","journal-title":"Cancer"},{"issue":"2","key":"1500_CR92","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11764-020-00922-7","volume":"15","author":"AC Lo","year":"2021","unstructured":"Lo AC, Samuel V, Chen B, Savage KJ, Freeman C, Goddard K. Evaluation of the discussion of late effects and screening recommendations in survivors of adolescent and young adult (AYA) lymphoma. J Cancer Surviv. 2021;15(2):179\u201389.","journal-title":"J Cancer Surviv"},{"issue":"12","key":"1500_CR93","doi-asserted-by":"publisher","first-page":"1726","DOI":"10.1001\/jamainternmed.2017.4747","volume":"177","author":"EB Rubinstein","year":"2017","unstructured":"Rubinstein EB, Miller WL, Hudson SV, Howard J, O\u2019Malley D, Tsui J, Lee HS, Bator A, Crabtree BF. Cancer survivorship care in advanced primary care practices: a qualitative study of challenges and opportunities. JAMA Intern Med. 2017;177(12):1726\u201332.","journal-title":"JAMA Intern Med"},{"issue":"5","key":"1500_CR94","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1200\/JOP.2010.000208","volume":"7","author":"MM Shalom","year":"2011","unstructured":"Shalom MM, Hahn EE, Casillas J, Ganz PA. Do survivorship care plans make a difference? A primary care provider perspective. J Oncol Pract. 2011;7(5):314\u20138.","journal-title":"J Oncol Pract"},{"key":"1500_CR95","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.ejon.2018.01.011","volume":"35","author":"K Taylor","year":"2018","unstructured":"Taylor K, Monterosso L, Bulsara C. Qualitative results from a phase II pilot randomised controlled trial of a lymphoma nurse-led model of survivorship care. Eur J Oncol Nurs. 2018;35:9\u201314.","journal-title":"Eur J Oncol Nurs"},{"issue":"6","key":"1500_CR96","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1007\/s13187-019-01574-7","volume":"35","author":"CJ Berg","year":"2020","unstructured":"Berg CJ, Vanderpool RC, Getachew B, Payne JB, Johnson MF, Sandridge Y, Bierhoff J, Le L, Johnson R, Weber A, Patterson A, Dorvil S, Mertens A. A hope-based intervention to address disrupted goal pursuits and quality of life among young adult cancer survivors. J Cancer Educ. 2020;35(6):1158\u201369.","journal-title":"J Cancer Educ"},{"issue":"2","key":"1500_CR97","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1002\/jcsm.12382","volume":"10","author":"H Arrieta","year":"2019","unstructured":"Arrieta H, Astrugue C, Regueme S, Durrieu J, Maillard A, Rieger A, Terrebonne E, Laurent C, Maget B, Servent V, Lavau-Den\u00e8s S, Dauba J, Fonck M, Thi\u00e9baut R, Bourdel-Marchasson I. Effects of a physical activity programme to prevent physical performance decline in onco-geriatric patients: a randomized multicentre trial. J Cachexia Sarcopenia Muscle. 2019;10(2):287\u201397.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"4","key":"1500_CR98","doi-asserted-by":"publisher","first-page":"e80","DOI":"10.1200\/JOP.2011.000401","volume":"8","author":"DK Mayer","year":"2012","unstructured":"Mayer DK, Gerstel A, Leak AN, Smith SK. Patient and provider preferences for survivorship care plans. J Oncol Pract. 2012;8(4):e80\u20136.","journal-title":"J Oncol Pract"},{"issue":"5","key":"1500_CR99","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1080\/07347332.2017.1313352","volume":"35","author":"K Franco","year":"2017","unstructured":"Franco K, Shuk E, Philip E, Blanch-Hartigan D, Parker PA, Matasar M, Horwitz S, Kissane D, Banerjee SC, Bylund CL. Communication between oncologists and lymphoma survivors during follow-up consultations: a qualitative analysis. J Psychosoc Oncol. 2017;35(5):513\u201330.","journal-title":"J Psychosoc Oncol"},{"issue":"3","key":"1500_CR100","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s11764-019-00756-y","volume":"13","author":"P Viscuse","year":"2019","unstructured":"Viscuse P, Yost KJ, Jenkins S, Lackore K, Habermann T, Thanarajasingam G, Thompson C. Impact of lymphoma survivorship clinic visit on patient-centered outcomes. J Cancer Surviv. 2019;13(3):344\u201352.","journal-title":"J Cancer Surviv"},{"key":"1500_CR101","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.ejon.2019.03.005","volume":"40","author":"K Taylor","year":"2019","unstructured":"Taylor K, Chivers P, Bulsara C, Joske D, Bulsara M, Monterosso L. Care After Lymphoma (CALy) trial: a phase II pilot pragmatic randomised controlled trial of a nurse-led model of survivorship care. Eur J Oncol Nurs. 2019;40:53\u201362.","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"1500_CR102","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1470-2045(19)30675-8","volume":"21","author":"A van der Hout","year":"2020","unstructured":"van der Hout A, van Uden-Kraan CF, Holtmaat K, Jansen F, Lissenberg-Witte BI, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. Role of eHealth application Oncokompas in supporting self-management of symptoms and health-related quality of life in cancer survivors: a randomised, controlled trial. Lancet Oncol. 2020;21(1):80\u201394.","journal-title":"Lancet Oncol"},{"issue":"4","key":"1500_CR103","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1080\/0284186X.2020.1851764","volume":"60","author":"A van der Hout","year":"2021","unstructured":"van der Hout A, Holtmaat K, Jansen F, Lissenberg-Witte BI, van Uden-Kraan CF, Nieuwenhuijzen GAP, Hardillo JA, Baatenburg de Jong RJ, Tiren-Verbeet NL, Sommeijer DW, de Heer K, Schaar CG, Sedee RJE, Bosscha K, van den Brekel MWM, Petersen JF, Westerman M, Honings J, Takes RP, Houtenbos I, van den Broek WT, de Bree R, Jansen P, Eerenstein SEJ, Leemans CR, Zijlstra JM, Cuijpers P, van de Poll-Franse LV, Verdonck-de Leeuw IM. The eHealth self-management application \u2018Oncokompas\u2019 that supports cancer survivors to improve health-related quality of life and reduce symptoms: which groups benefit most? Acta Oncol. 2021;60(4):403\u201311.","journal-title":"Acta Oncol"},{"issue":"15","key":"1500_CR104","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1200\/JCO.2013.51.7540","volume":"32","author":"D Blanch-Hartigan","year":"2014","unstructured":"Blanch-Hartigan D, Forsythe LP, Alfano CM, Smith T, Nekhlyudov L, Ganz PA, Rowland JH. Provision and discussion of survivorship care plans among cancer survivors: results of a nationally representative survey of oncologists and primary care physicians. J Clin Oncol. 2014;32(15):1578\u201385.","journal-title":"J Clin Oncol"},{"issue":"20","key":"1500_CR105","doi-asserted-by":"publisher","first-page":"3338","DOI":"10.1200\/JCO.2008.20.4883","volume":"27","author":"ME Del Giudice","year":"2009","unstructured":"Del Giudice ME, Grunfeld E, Harvey BJ, Piliotis E, Verma S. Primary care physicians\u2019 views of routine follow-up care of cancer survivors. J Clin Oncol. 2009;27(20):3338\u201345.","journal-title":"J Clin Oncol"},{"issue":"11","key":"1500_CR106","doi-asserted-by":"publisher","first-page":"2951","DOI":"10.1007\/s11136-019-02244-3","volume":"28","author":"S Hathiramani","year":"2019","unstructured":"Hathiramani S, Pettengell R, Moir H, Younis A. Lymphoma survivors\u2019 experience of participation in a home-based intervention post-chemotherapy. Qual Life Res. 2019;28(11):2951\u20135.","journal-title":"Qual Life Res"},{"key":"1500_CR107","doi-asserted-by":"publisher","first-page":"101838","DOI":"10.1016\/j.ejon.2020.101838","volume":"49","author":"N Lize","year":"2020","unstructured":"Lize N, Raijmakers N, van Lieshout R, Youssef-El Soud M, van Limpt A, van der Linden M, Beijer S. Psychosocial consequences of a reduced ability to eat for patients with cancer and their informal caregivers: a qualitative study. Eur J Oncol Nurs. 2020;49:101838.","journal-title":"Eur J Oncol Nurs"},{"issue":"1","key":"1500_CR108","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1007\/s11764-016-0559-y","volume":"11","author":"CM Moinpour","year":"2017","unstructured":"Moinpour CM, Unger JM, Ganz PA, Kornblith AB, Gaynor ER, Bowers MA, Gatti GS, Kaminski MS, Erba HP, Wang T, Yoon J, Press OW, Fisher RI. Seven-year follow-up for energy\/vitality outcomes in early stage Hodgkin\u2019s disease patients treated with subtotal lymphoid irradiation versus chemotherapy plus radiation: SWOG S9133 and its QOL companion study, S9208. J Cancer Surviv. 2017;11(1):32\u201340.","journal-title":"J Cancer Surviv"},{"issue":"6","key":"1500_CR109","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1200\/JCO.2007.12.3414","volume":"26","author":"SK Smith","year":"2008","unstructured":"Smith SK, Zimmerman S, Williams CS, Preisser JS, Clipp EC. Post-traumatic stress outcomes in non-Hodgkin\u2019s lymphoma survivors. J Clin Oncol. 2008;26(6):934\u201341.","journal-title":"J Clin Oncol"},{"issue":"14","key":"1500_CR110","doi-asserted-by":"publisher","first-page":"2122","DOI":"10.1002\/cncr.28698","volume":"120","author":"SR Pingali","year":"2014","unstructured":"Pingali SR, Jewell SW, Havlat L, Bast MA, Thompson JR, Eastwood DC, Bartlett NL, Armitage JO, Wagner-Johnston ND, Vose JM, Fenske TS. Limited utility of routine surveillance imaging for classical Hodgkin lymphoma patients in first complete remission. Cancer. 2014;120(14):2122\u20139.","journal-title":"Cancer"},{"issue":"31","key":"1500_CR111","doi-asserted-by":"publisher","first-page":"3506","DOI":"10.1200\/JCO.2014.55.7561","volume":"32","author":"CA Thompson","year":"2014","unstructured":"Thompson CA, Ghesquieres H, Maurer MJ, Cerhan JR, Biron P, Ansell SM, Chassagne-Cl\u00e9ment C, Inwards DJ, Gargi T, Johnston PB, Nicolas-Virelizier E, Macon WR, Peix M, Micallef IN, Sebban C, Nowakowski GS, Porrata LF, Weiner GJ, Witzig TE, Habermann TM, Link BK. Utility of routine post-therapy surveillance imaging in diffuse large B-cell lymphoma. J Clin Oncol. 2014;32(31):3506\u201312.","journal-title":"J Clin Oncol"},{"issue":"2","key":"1500_CR112","doi-asserted-by":"publisher","first-page":"48","DOI":"10.7812\/TPP\/14-241","volume":"19","author":"BI Bodai","year":"2015","unstructured":"Bodai BI, Tuso P. Breast cancer survivorship: a comprehensive review of long-term medical issues and lifestyle recommendations. Perm J. 2015;19(2):48\u201379.","journal-title":"Perm J"},{"issue":"2","key":"1500_CR113","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1093\/fampra\/cmu082","volume":"32","author":"M Luctkar-Flude","year":"2015","unstructured":"Luctkar-Flude M, Aiken A, McColl MA, Tranmer J. A comprehensive framework and key guideline recommendations for the provision of evidence-based breast cancer survivorship care within the primary care setting. Fam Pract. 2015;32(2):129\u201340.","journal-title":"Fam Pract"},{"issue":"Suppl 4","key":"1500_CR114","doi-asserted-by":"publisher","first-page":"iv19","DOI":"10.1093\/annonc\/mdy080","volume":"29","author":"DA Eichenauer","year":"2018","unstructured":"Eichenauer DA, Aleman BMP, Andr\u00e9 M, Federico M, Hutchings M, Illidge T, Engert A, Ladetto M, ESMO Guidelines Committee. Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2018;29(Suppl 4):iv19\u201329.","journal-title":"Ann Oncol"},{"key":"1500_CR115","unstructured":"Children\u2019s Oncology Group. Long-term follow-up guidelines for survivors of childhood, adolescent, and young adult cancers. (Version 5.0). 2018. http:\/\/www.survivorshipguidelines.org\/pdf\/2018\/cog_ltfu_guidelines_v5.pdf. Accessed 10 August 2023."},{"key":"1500_CR116","unstructured":"National Comprehensive Cancer Network. Breast screening guideline. [date unknown]. https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast-screening.pdf. Accessed 10 August 2023."},{"key":"1500_CR117","unstructured":"National Comprehensive Cancer Centre. Colorectal cancer screening guideline. https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/colorectal-screening-patient.pdf. Accessed 10 August 2023."},{"key":"1500_CR118","unstructured":"National Comprehensive Cancer Network. Lung screening guideline. [date unknown]. https:\/\/www.nccn.org\/patients\/guidelines\/content\/PDF\/lung_screening-patient.pdf. Accessed 10 August 2023."},{"key":"1500_CR119","unstructured":"Centre for Disease Control. Adult immunization schedule by age. 2023. https:\/\/www.cdc.gov\/vaccines\/schedules\/hcp\/imz\/adult.html#table-age. Accessed 10 August 2023."},{"key":"1500_CR120","unstructured":"National Comprehensive Cancer Network. NCCN guidelines treatment by cancer type. 2023. https:\/\/www.nccn.org\/guidelines\/category_1. Accessed 10 August 2023."},{"key":"1500_CR121","unstructured":"National Cancer Institute. Sleep problems in people with cancer. 2021. https:\/\/www.cancer.gov\/about-cancer\/treatment\/side-effects\/sleep-problems. Accessed 13 September 2022."},{"key":"1500_CR122","unstructured":"American Society of Clinical Oncology. Screening and assessment-fatigue in cancer survivors. [date unknown]. https:\/\/old-prod.asco.org\/sites\/new-www.asco.org\/files\/content-files\/practice-and-guidelines\/documents\/fatigue-algorithm.pdf. Accessed 13 September 2022."},{"issue":"4","key":"1500_CR123","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1200\/JOP.2016.018770","volume":"13","author":"SH Armenian","year":"2017","unstructured":"Armenian SH, Lacchetti C, Lenihan D. Prevention and monitoring of cardiac dysfunction in survivors of adult cancers: American Society of Clinical Oncology Clinical Practice Guideline summary. J Oncol Pract. 2017;13(4):270\u20135.","journal-title":"J Oncol Pract"},{"key":"1500_CR124","doi-asserted-by":"publisher","first-page":"vii155","DOI":"10.1093\/annonc\/mds293","volume":"23 Suppl 7","author":"G Curigliano","year":"2012","unstructured":"Curigliano G, Cardinale D, Suter T, Plataniotis G, de Azambuja E, Sandri MT, Criscitiello C, Goldhirsch A, Cipolla C, Roila F, ESMO Guidelines Working Group. Cardiovascular toxicity induced by chemotherapy, targeted agents and radiotherapy: ESMO Clinical Practice Guidelines. Ann Oncol. 2012;23 Suppl 7:vii155-66.","journal-title":"Ann Oncol"}],"container-title":["Journal of Cancer Survivorship"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01500-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11764-023-01500-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11764-023-01500-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,22]],"date-time":"2025-03-22T03:03:21Z","timestamp":1742612601000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11764-023-01500-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,4]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["1500"],"URL":"https:\/\/doi.org\/10.1007\/s11764-023-01500-3","relation":{},"ISSN":["1932-2259","1932-2267"],"issn-type":[{"value":"1932-2259","type":"print"},{"value":"1932-2267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,4]]},"assertion":[{"value":"11 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Scoping literature review, ethics approval was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}